Mouse models of diabetic nephropathy.

Area of Science:

• Nephrology
• Diabetology
• Translational Medicine

Background:

• Diabetic nephropathy is a leading cause of end-stage renal disease (ESRD) globally.
• A significant barrier to research is the absence of accurate animal models for diabetic kidney disease.
• The Animal Models of Diabetic Complications Consortium (AMDCC) was established to address this gap.

Purpose of the Study:

• To report on the progress of developing and validating murine models for diabetic nephropathy.
• To assess current models and identify future research directions for diabetic kidney disease.

Main Methods:

• Development and characterization of murine models for diabetic nephropathy.
• Establishment of validation criteria for early and advanced disease stages.
• Phenotyping methods and assessment of genetic background effects on nephropathy.

Main Results:

• No single murine model fully replicates human diabetic kidney disease to date.
• Critical analysis of existing models has improved understanding of the disease process.
• Progress has been made in defining criteria and methods for model validation.

Conclusions:

• While a complete murine model for human diabetic nephropathy remains elusive, ongoing research significantly advances the field.
• The AMDCC's work is crucial for refining and validating animal models to study diabetic kidney disease.
• Further development is needed to create a comprehensive model for predicting and treating diabetic nephropathy.